Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by mcarter4on Sep 01, 2004 8:24am

213 Views

Post# 7872661

RE: Very funny

Hey goofy, <> Are you seriously retarded or just a management apologist?? I never actually compared BT etc. to those other folk. I was responding to your incredibly retarded post (of which you seem to make many). You were the one who I believe posited a hypothetical situation and I was responding to that retarded hypothetical situation. Get a grip and learn to read. Even better stop posting garbage and do us all a favour. <> Toofast, I'm guessing your the kind of guy who likes watching his wife get screwed by real men. <> You ain't my friend. And as you are an idiot I can't prescribe any help for you.

Bullboard Posts

POET increases production capacity to meet AI demand